Revenue
No reported data
INTENSITY THERAPEUTICS, INC. (INTS)
Price—Loading quote
Net income
2022
2023
2024
2025
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Research & development | $6.8M | $10.5M | $4.8M | $5.1M |
| Operating expenses | $12.0M | $16.6M | $8.3M | $7.5M |
| Operating income | −$12.0M | −$16.6M | −$8.3M | −$7.5M |
| Net income | −$11.6M | −$16.3M | −$10.5M | −$7.6M |
| Basic EPSper diluted share | -$8.56 | -$29.24 | -$1.38 | -$2.22 |
| Diluted EPSper diluted share | -$8.56 | -$29.24 | -$1.38 | -$2.22 |